WHO ICTRP trial
Study to Evaluate the pharmacokinetic characteristics of the JLP-1310(1000/10mg)
KCT0003623 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0003623 |
|---|---|
| Public title | Study to Evaluate the pharmacokinetic characteristics of the JLP-1310(1000/10mg) |
| Scientific title | A randomized, open-label, single dose, crossover study to compare the pharmacokinetic characteristics of the co-administration of metformin SR and rosuvastatin and JLP-1310(1000/10mg) in healthy male volunteers |
| Primary sponsor | Inha University Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase1 |
| Countries | Korea, Republic of |
| Conditions | Endocrine, nutritional and metabolic disease |
| Interventions | Drug : arm A : metformin+rosuvastatin / JLP-1310(1000/10mg) arm B : JLP-1310(1000/10mg) /metformin +rosuvastatin |
| Registration date | Mar 14, 2019 |
| Target size | 40 |
| Secondary IDs | NCT03690778 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: